Acrivon Therapeutics Total Assets

Acrivon Therapeutics (ACRV) currently reports a total assets of $110M as of March 2026. That compares with $180M in the prior-year period — down 38.9% year over year. Use the charts on this page to explore Acrivon Therapeutics's total assets history and peer comparisons.

Acrivon Therapeutics's total assets decreased from $180M to $110M — a 38.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acrivon Therapeutics reported $110M in total assets as of March 2026. That compares with $180M in the prior-year period — down 38.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acrivon Therapeutics, and consider following ACRV for alerts when major investors trade the stock.